Photocure Q3 Adjusted EBITDA at NOK 18.5 Million
Valid market news retained in the public archive without immediate LiveCast distribution.
Related stories
Eli Lilly Expects Mounjaro to Maintain U.S. Leadership
Finance chief Lucas Montarce said Mounjaro’s U.S. revenue gained 41% to $5 billion in the latest quarter and pointed to strength outside the U.S.
M impact | EARNINGS | Oct 29, 2026, 03:55 PM UTC
Merck Plans to Raise Revenue Forecast for Next Decade
Merck plans to raise its revenue forecast for the next decade, citing optimism about new medicines.
M impact | EARNINGS | Oct 29, 2026, 03:50 PM UTC
Lilly Says Bridge Program Boosts GLP-1 Sales and Supports Raised Guidance
Eli Lilly says its U.S. Bridge program is boosting sales of its GLP-1 drugs and was a key driver of its raised full-year revenue guidance. The program started in July.
M impact | EARNINGS | Oct 29, 2026, 03:50 PM UTC
ADAMA Reports Q3 Sales Down 4% to $897 Million
ADAMA reported third-quarter sales of $897 million, down 4%.
M impact | EARNINGS | Oct 29, 2026, 03:46 PM UTC
Howmet Raises Full-Year Guidance on Robust Aircraft-Parts Demand
Howmet raised its full-year forecasts, citing robust demand for aircraft parts.
M impact | EARNINGS | Oct 29, 2026, 03:46 PM UTC
Rafael Holdings Reports FY 2026 Revenue of $874K, Net Loss of $29.6M
The company’s attributable net loss narrowed from $30.5 million a year earlier, while its consolidated net loss was $28 million. Operating loss widened to $33.4 million.
M impact | EARNINGS | Oct 29, 2026, 03:45 PM UTC